vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.
POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $185.2M, roughly 1.7× AMICUS THERAPEUTICS, INC.). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs 0.9%, a 7.3% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 23.1%). POTLATCHDELTIC CORP produced more free cash flow last quarter ($50.1M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 11.1%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
POTLATCHDELTIC CORPPCHEarnings & Financial Report
PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.
FOLD vs PCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $314.2M |
| Net Profit | $1.7M | $25.9M |
| Gross Margin | 85.7% | 18.2% |
| Operating Margin | 8.6% | 11.2% |
| Net Margin | 0.9% | 8.2% |
| Revenue YoY | 23.7% | 23.1% |
| Net Profit YoY | -88.5% | 682.5% |
| EPS (diluted) | $0.00 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | — | ||
| Q3 25 | $169.1M | $314.2M | ||
| Q2 25 | $154.7M | $275.0M | ||
| Q1 25 | $125.2M | $268.3M | ||
| Q4 24 | $149.7M | $258.1M | ||
| Q3 24 | $141.5M | $255.1M | ||
| Q2 24 | $126.7M | $320.7M | ||
| Q1 24 | $110.4M | $228.1M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $17.3M | $25.9M | ||
| Q2 25 | $-24.4M | $7.4M | ||
| Q1 25 | $-21.7M | $25.8M | ||
| Q4 24 | $14.7M | $5.2M | ||
| Q3 24 | $-6.7M | $3.3M | ||
| Q2 24 | $-15.7M | $13.7M | ||
| Q1 24 | $-48.4M | $-305.0K |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | 18.2% | ||
| Q2 25 | 90.2% | 13.0% | ||
| Q1 25 | 90.7% | 17.8% | ||
| Q4 24 | 90.1% | 13.4% | ||
| Q3 24 | 90.6% | 10.8% | ||
| Q2 24 | 91.1% | 11.9% | ||
| Q1 24 | 87.7% | 7.0% |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.3% | 11.2% | ||
| Q2 25 | -6.1% | 5.0% | ||
| Q1 25 | -6.3% | 10.3% | ||
| Q4 24 | 10.7% | 5.2% | ||
| Q3 24 | 15.3% | 2.8% | ||
| Q2 24 | 11.8% | 5.4% | ||
| Q1 24 | -25.1% | -2.1% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 10.2% | 8.2% | ||
| Q2 25 | -15.8% | 2.7% | ||
| Q1 25 | -17.3% | 9.6% | ||
| Q4 24 | 9.8% | 2.0% | ||
| Q3 24 | -4.8% | 1.3% | ||
| Q2 24 | -12.4% | 4.3% | ||
| Q1 24 | -43.9% | -0.1% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | $0.06 | $0.33 | ||
| Q2 25 | $-0.08 | $0.09 | ||
| Q1 25 | $-0.07 | $0.33 | ||
| Q4 24 | $0.05 | $0.07 | ||
| Q3 24 | $-0.02 | $0.04 | ||
| Q2 24 | $-0.05 | $0.17 | ||
| Q1 24 | $-0.16 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $88.8M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.9B |
| Total Assets | $949.9M | $3.2B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | $88.8M | ||
| Q2 25 | $231.0M | $95.3M | ||
| Q1 25 | $250.6M | $147.5M | ||
| Q4 24 | $249.9M | $151.6M | ||
| Q3 24 | $249.8M | $161.1M | ||
| Q2 24 | $260.1M | $199.7M | ||
| Q1 24 | $239.6M | $180.2M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | $1.0B | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | — | ||
| Q3 25 | $230.4M | $1.9B | ||
| Q2 25 | $204.3M | $1.9B | ||
| Q1 25 | $193.6M | $2.0B | ||
| Q4 24 | $194.0M | $2.0B | ||
| Q3 24 | $178.8M | $2.1B | ||
| Q2 24 | $132.5M | $2.1B | ||
| Q1 24 | $130.7M | $2.2B |
| Q4 25 | $949.9M | — | ||
| Q3 25 | $868.8M | $3.2B | ||
| Q2 25 | $815.3M | $3.2B | ||
| Q1 25 | $789.8M | $3.3B | ||
| Q4 24 | $785.0M | $3.3B | ||
| Q3 24 | $786.6M | $3.3B | ||
| Q2 24 | $749.5M | $3.4B | ||
| Q1 24 | $721.8M | $3.4B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 0.51× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $65.7M |
| Free Cash FlowOCF − Capex | $16.0M | $50.1M |
| FCF MarginFCF / Revenue | 8.6% | 15.9% |
| Capex IntensityCapex / Revenue | 0.2% | 4.9% |
| Cash ConversionOCF / Net Profit | 9.62× | 2.54× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $132.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | — | ||
| Q3 25 | $35.7M | $65.7M | ||
| Q2 25 | $-26.5M | $41.0M | ||
| Q1 25 | $7.8M | $49.1M | ||
| Q4 24 | $-3.9M | $45.4M | ||
| Q3 24 | $-23.0M | $26.5M | ||
| Q2 24 | $22.7M | $100.6M | ||
| Q1 24 | $-29.7M | $16.0M |
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | $50.1M | ||
| Q2 25 | $-28.9M | $30.6M | ||
| Q1 25 | $7.5M | $26.3M | ||
| Q4 24 | $-4.2M | $25.4M | ||
| Q3 24 | $-23.3M | $-8.2M | ||
| Q2 24 | $21.6M | $72.4M | ||
| Q1 24 | $-31.5M | $2.0M |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.9% | 15.9% | ||
| Q2 25 | -18.7% | 11.1% | ||
| Q1 25 | 6.0% | 9.8% | ||
| Q4 24 | -2.8% | 9.9% | ||
| Q3 24 | -16.5% | -3.2% | ||
| Q2 24 | 17.0% | 22.6% | ||
| Q1 24 | -28.5% | 0.9% |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | 4.9% | ||
| Q2 25 | 1.6% | 3.8% | ||
| Q1 25 | 0.2% | 8.5% | ||
| Q4 24 | 0.2% | 7.7% | ||
| Q3 24 | 0.3% | 13.6% | ||
| Q2 24 | 0.9% | 8.8% | ||
| Q1 24 | 1.6% | 6.1% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 2.54× | ||
| Q2 25 | — | 5.58× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | -0.27× | 8.74× | ||
| Q3 24 | — | 7.99× | ||
| Q2 24 | — | 7.35× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
